Invesco
ORKA

Invesco’s Oruka Therapeutics ORKA Stock Holding History

Invesco’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.76M Sell
97,042
-46,079
-32% -$1.6M ﹤0.01% 2220
2025
Q4 		$4.34M Buy
143,121
+126,803
+777% +$3.53M ﹤0.01% 2307
2025
Q3 		$314K Buy
16,318
+1,008
+7% +$14.9K ﹤0.01% 3400
2025
Q2 		$172K Buy
+15,310
New +$160K ﹤0.01% 3554
2014
Q1 		– Hold
0
– – – 4316
2013
Q4 		– Hold
0
– – – 4383
2013
Q3 		– Hold
0
– – – 4347
2013
Q2 		– Hold
0
– – – 4292

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return